{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:51:44Z","timestamp":1791996704951,"version":"4.4.0"},"update-to":[{"DOI":"10.1016\/j.omto.2020.03.009","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000}}],"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncolytics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.omto.2020.03.009","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T04:36:59Z","timestamp":1585543019000},"page":"83-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["RETRACTED: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT\/p70S6K and JNK Pathways through ABHD2"],"prefix":"10.1016","volume":"17","author":[{"given":"Yuanmin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2020.03.009_bib1","first-page":"18","article-title":"A Global Review of Melanoma Follow-up Guidelines","volume":"6","author":"Trotter","year":"2013","journal-title":"J.\u00a0Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.omto.2020.03.009_bib2","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omto.2020.03.009_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omto.2020.03.009_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2015.01.016","article-title":"Targeting drivers of melanoma with synthetic small molecules and phytochemicals","volume":"359","author":"Strickland","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omto.2020.03.009_bib5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Eggermont","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.omto.2020.03.009_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2007.12.7837","article-title":"Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials","volume":"26","author":"Korn","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2020.03.009_bib7","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S1470-2045(16)30578-2","article-title":"Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials","volume":"17","author":"Long","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omto.2020.03.009_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrc2619","article-title":"MicroRNAs\u2014the micro steering wheel of tumour metastases","volume":"9","author":"Nicoloso","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2020.03.009_bib9","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1002\/jcb.26599","article-title":"MicroRNAs and exosomes in depression: Potential diagnostic biomarkers","volume":"119","author":"Tavakolizadeh","year":"2018","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.omto.2020.03.009_bib10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/jcb.26271","article-title":"Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome","volume":"119","author":"Saeedi Borujeni","year":"2018","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.omto.2020.03.009_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.acc.2017.06.004","article-title":"Cytokines and MicroRNA in Coronary Artery Disease","volume":"82","author":"Mirzaei","year":"2017","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.omto.2020.03.009_bib12","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1002\/jcb.26012","article-title":"MicroRNAs-Based Imaging Techniques in Cancer Diagnosis and Therapy","volume":"118","author":"Keshavarzi","year":"2017","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.omto.2020.03.009_bib13","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1002\/jcp.26395","article-title":"MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers","volume":"233","author":"Ross","year":"2018","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.omto.2020.03.009_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2015.10.009","article-title":"MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma","volume":"53","author":"Mirzaei","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.omto.2020.03.009_bib15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/carcin\/bgs205","article-title":"MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy","volume":"33","author":"Segura","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.omto.2020.03.009_bib16","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omto.2020.03.009_bib17","doi-asserted-by":"crossref","first-page":"14885","DOI":"10.1002\/jcb.28750","article-title":"Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN","volume":"120","author":"Zhang","year":"2019","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.omto.2020.03.009_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13058-018-1074-z","article-title":"The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer","volume":"20","author":"Bhardwaj","year":"2018","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.omto.2020.03.009_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2009.01.098","article-title":"Age-related pulmonary emphysema in mice lacking alpha\/beta hydrolase domain containing 2 gene","volume":"380","author":"Jin","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omto.2020.03.009_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbrc.2007.10.127","article-title":"Elevated mature macrophage expression of human ABHD2 gene in vulnerable plaque","volume":"365","author":"Miyata","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omto.2020.03.009_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejca.2016.01.002","article-title":"Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration","volume":"57","author":"Obinata","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.omto.2020.03.009_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bmb\/ldu019","article-title":"Management of melanoma","volume":"111","author":"Corrie","year":"2014","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.omto.2020.03.009_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2018.01.029","article-title":"The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model","volume":"419","author":"Mirzaei","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omto.2020.03.009_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2174\/0929867323666151217122033","article-title":"Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents","volume":"23","author":"Mirzaei","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.omto.2020.03.009_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omto.2020.03.009_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-319-56246-9_18","article-title":"[MiR-140-3p Downregulation in Association with PDL-1 Overexpression in Many Cancers: A Review from the Literature Using Predictive Bioinformatics Tools]","volume":"988","author":"Kapodistrias","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omto.2020.03.009_bib27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1302\/2046-3758.611.BJR-2017-0090.R1","article-title":"Dysregulation of both miR-140-3p and miR-140-5p in synovial fluid correlate with osteoarthritis severity","volume":"6","author":"Yin","year":"2017","journal-title":"Bone Joint Res."},{"key":"10.1016\/j.omto.2020.03.009_bib28","first-page":"516","article-title":"Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study","volume":"38","author":"Karakas","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.omto.2020.03.009_bib29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fnmol.2017.00250","article-title":"Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder","volume":"10","author":"Cirnigliaro","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omto.2020.03.009_bib30","first-page":"3835","article-title":"miR-140-3p inhibits breast cancer proliferation and migration by directly regulating the expression of tripartite motif 28","volume":"17","author":"Zhou","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.omto.2020.03.009_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2019.01.007","article-title":"miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9","volume":"446","author":"Huang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omto.2020.03.009_bib32","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","article-title":"In\u00a0vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors","volume":"51","author":"Giard","year":"1973","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.omto.2020.03.009_bib33","first-page":"1503","article-title":"Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium","volume":"36","author":"Chee","year":"1976","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2020.03.009_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-4598-11-22","article-title":"Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines","volume":"11","author":"von Euw","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omto.2020.03.009_bib35","doi-asserted-by":"crossref","first-page":"e2071","DOI":"10.3390\/ijms20092071","article-title":"Retinoic Acid Induces Differentiation of Mouse F9 Embryonic Carcinoma Cell by Modulating the miR-485 Targeting of Abhd2","volume":"20","author":"Yu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omto.2020.03.009_bib36","doi-asserted-by":"crossref","first-page":"47620","DOI":"10.18632\/oncotarget.9951","article-title":"Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer","volume":"7","author":"Yamanoi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2020.03.009_bib37","doi-asserted-by":"crossref","first-page":"L460","DOI":"10.1152\/ajplung.00041.2012","article-title":"miR-140-3p regulation of TNF-\u03b1-induced CD38 expression in human airway smooth muscle cells","volume":"303","author":"Jude","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.omto.2020.03.009_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3349\/ymj.2019.60.6.561","article-title":"miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT\/mTOR Signaling","volume":"60","author":"Wu","year":"2019","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.omto.2020.03.009_bib39","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/acschembio.9b00083","article-title":"JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells","volume":"14","author":"Du","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omto.2020.03.009_bib40","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3892\/ijo.2016.3594","article-title":"Targeting the PI3K\/AKT\/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor","volume":"49","author":"Caporali","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omto.2020.03.009_bib41","doi-asserted-by":"crossref","first-page":"e40378","DOI":"10.1371\/journal.pone.0040378","article-title":"The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion","volume":"7","author":"Fenouille","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omto.2020.03.009_bib42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbrc.2017.06.195","article-title":"Regulation of calcium release from the endoplasmic reticulum by the serine hydrolase ABHD2","volume":"490","author":"Yun","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omto.2020.03.009_bib43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41418-018-0171-y","article-title":"STAT3 localizes to the ER, acting as a gatekeeper for ER-mitochondrion Ca2+ fluxes and apoptotic responses","volume":"26","author":"Avalle","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omto.2020.03.009_bib44","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1038\/onc.2008.308","article-title":"Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis","volume":"27","author":"Pinton","year":"2008","journal-title":"Oncogene"}],"updated-by":[{"DOI":"10.1016\/j.omto.2023.100742","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"record-id":"49881"},{"DOI":"10.1016\/j.omto.2020.03.009","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000}},{"DOI":"10.1016\/j.omto.2023.100742","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000}}],"container-title":["Molecular Therapy Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520300346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520300346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:39:00Z","timestamp":1791995940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770520300346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":44,"alternative-id":["S2372770520300346"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2020.03.009","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT\/p70S6K and JNK Pathways through ABHD2","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2020.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}